Literature DB >> 11233080

Analgesic and anti-inflammatory effects of phosphodiesterase inhibitors.

A Kumar1, N K Jain, S K Kulkarni.   

Abstract

The aim of the present study was to investigate the role of phosphodiesterase (PDE) enzyme inhibitors namely rolipram and theophylline in pain and inflammation in experimental animals. Rolipram, a selective PDE IV inhibitor and theophylline a nonspecific PDE inhibitor exerted dose dependent analgesic and anti-inflammatory effect against acetic acid-induced writhing in mice and carrageenan-induced paw edema in rats, respectively. Nimesulide (1, 2 mg/kg) produced significant anti-inflammatory effect. Further, nimesulide (0.5 mg/kg) potentiated analgesic effect of rolipram but it failed to modulate the anti-inflammatory effect of PDE inhibitors. Present study suggests that PDE enzymes might be playing a role in nociceptive and inflammatory responses in animals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11233080

Source DB:  PubMed          Journal:  Indian J Exp Biol        ISSN: 0019-5189            Impact factor:   0.818


  5 in total

1.  Analgesic and Antiinflammatory activity of Amukkarac curanam.

Authors:  A Saraswathy; S Nandini Devi; R V Pradeep Chandran
Journal:  Indian J Pharm Sci       Date:  2009-07       Impact factor: 0.975

2.  Enhancement of the anti-inflammatory and anti-arthritic effects of theophylline by a low dose of a nitric oxide donor or non-specific nitric oxide synthase inhibitor.

Authors:  Adel Gomaa; Mohsen Elshenawy; Noha Afifi; Eman Mohammed; Romany Thabit
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

3.  Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B).

Authors:  Han-Ting Zhang; Ying Huang; Anbrin Masood; Lisa R Stolinski; Yunfeng Li; Lei Zhang; Daniel Dlaboga; S-L Catherine Jin; Marco Conti; James M O'Donnell
Journal:  Neuropsychopharmacology       Date:  2007-08-15       Impact factor: 7.853

4.  The analgesic effect of rolipram is associated with the inhibition of the activation of the spinal astrocytic JNK/CCL2 pathway in bone cancer pain.

Authors:  Chi-Hua Guo; Lu Bai; Huang-Hui Wu; Jing Yang; Guo-Hong Cai; Xin Wang; Sheng-Xi Wu; Wei Ma
Journal:  Int J Mol Med       Date:  2016-09-30       Impact factor: 4.101

Review 5.  Inhibition of the Soluble Epoxide Hydrolase as an Analgesic Strategy: A Review of Preclinical Evidence.

Authors:  Yuxin Wang; Karen M Wagner; Christophe Morisseau; Bruce D Hammock
Journal:  J Pain Res       Date:  2021-01-13       Impact factor: 3.133

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.